About Us
PARTNERS
A2 Bio Partnerships
A2 Bio has a research collaboration with Merck for its first allogeneic program and an option for a second program. This is Merck’s first partnership in the cell therapy area, and their decision to partner with A2 Bio serves as a validation of the Tmod™ platform. Learn More
A2 Bio has a diagnostic collaboration with Tempus, a leader in genetic diagnostic testing, artificial intelligence and precision medicine, to develop a companion diagnostic to identify those patients whose tumors have lost HLA-A*02. This diagnostic technology can also be used to support the development of further diagnostic testing for future programs. Learn More